中文
Home
Protocols
Research fields
Biochemistry (1140)
Biophysics (87)
Cancer Biology (362)
Cell Biology (1668)
Developmental Biology (238)
Immunology (504)
Microbiology (986)
Molecular Biology (890)
Neuroscience (529)
Plant Science (905)
Stem Cell (196)
Systems Biology (253)
Bio-protocol journal
Special issues
Lab protocol hub
Request a Protocol
Submit
Submission procedure
Author guidelines
Submit a protocol
Editorial criteria
About
|
A high-quality database for basic life science protocols
Protocols
Research fields
Biochemistry (1140)
Biophysics (87)
Cancer Biology (362)
Cell Biology (1668)
Developmental Biology (238)
Immunology (504)
Microbiology (986)
Molecular Biology (890)
Neuroscience (529)
Plant Science (905)
Stem Cell (196)
Systems Biology (253)
Bio-protocol journal
Special issues
Lab protocol hub
Request a Protocol
Submit
Submission procedure
Author guidelines
Submit a protocol
Editorial criteria
About
This protocol was submitted by the author(s) of the original paper via Bio-protocol's "
Request a Protocol
" feature.
Original Research Paper
FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex
DOI: 10.7554/eLife.35012
eLIFE , Jun 13, 2018
Related protocols in the same article
+ Show more
Update your protocol
Concanavalin A enrichment
Matthew Freeman
Adam Graham Grieve
Original Research Paper
FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex
eLIFE
, Jun 13, 2018
DOI:
10.7554/eLife.35012
Last updated date: Apr 28, 2020
View: 630
Download PDF
How to cite
Copy protocol link
Q&A
How to cite:
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
1. Freeman, M. and Grieve, A. G.(2020). Concanavalin A enrichment. Bio-protocol.
bio-protocol.org/prep288
.
2. Künzel, U., Grieve, A., Meng, Y., Sieber, B., Cowley, S. and Freeman, M.(2018). FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex. eLIFE . DOI:
10.7554/eLife.35012
Copyright:
Content may be subjected to copyright.
Q&A
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.